I n response to a transmural myocardial infarction (MI), the left ventricle (LV) undergoes significant remodeling. 1 Progressive alterations in ventricular architecture occur in infarcted and noninfarcted regions. Typically, after initial inflammatory responses and scar formation, LV chamber volume increases, and there is a thinning of the chamber wall and a loss of contractility due to fibrosis. It is believed that initially remodeling is required for maintenance of cardiac output but ultimately leads to LV dysfunction. Clinical and experimental studies of MI have exposed a number of cellular changes that contribute to morphological and functional adaptations, including cardiac fibroblast proliferation, cardiac myocyte hypertrophy, and extracellular matrix (ECM) deposition.
A rat model of MI has been extensively used to better understand the functional, structural, and molecular changes associated with clinical ischemic heart disease. 2 Animals that survive with large transmural infarctions develop heart failure without another ischemic event, as is typically seen in humans. It is clear that substantial alterations in gene expression are needed to afford such profound changes within cells of the remodeling myocardium. Alterations in expression of several genes have been described in the rat model of MI. Changes in actin and myosin gene expression are associated with alterations in cytoskeleton and contractile apparatus in surviving myocytes. 3, 4 Fibrosis of LV myocardium is, in part, the result of elevated collagen and fibronectin expression. 5, 6 Atrial natriuretic peptide mRNA and protein levels in the cardiomyocyte are elevated in response to MI as a compensatory response to improve hemodynamics. 6, 7 In addition, certain cytokine genes, interleukins 1␤ and 6, and tumor necrosis factor-␣ are transcriptionally regulated in the remodeling MI rat heart. 8 Recent technological advances in the production of cDNA microarrays have made it possible to profile gene expression of tens of thousands of genes simultaneously. 9, 10 Highdensity arrays of cDNA inserts, Ͼ1000 genes per cm 2 , are produced on glass slides by high-speed robotic printing. Each printed cDNA insert on the microarray is suitable for molecular hybridization, thus allowing rapid assessment of mRNA expression of all arrayed genes in tissues of interest. Microarray analysis of gene expression has been applied to studies in yeast, Arabidopsis, Streptococcus, and mammalian cell lines. Disease-related changes in gene expression have been evaluated by microarray methods for cancer, 11 rheumatoid arthritis and inflammatory bowel disease, 12 and metabolic disorders. 13 We present here application of cDNA microarray technology to identify gene expression changes in the rat heart after infarction. Approximately 7000 cDNAs collected from rat heart cDNA libraries were printed onto microarrays and profiled for expression in the LV free wall and interventricular septum (IVS) at 2, 4, 8, 12, and 16 weeks after surgically induced MI in the rat. Patterns within a set of 731 differentially expressed genes have been identified with newly developed clustering algorithms. Many of the changes in expression are found in genes that encode proteins that have been implicated in cytoskeletal architecture, ECM, contractility, and metabolism.
of Laboratory Animal Care. MIs were produced in male Wistar rats (Coromed Inc, Troy, NY) by partial ligation of the coronary artery. Animals were sacrificed 2, 4, 8, 12, and 16 weeks after surgery by laparotomy under anesthesia. The heart of each animal was removed for histological evaluation and for the preparation of mRNA.
Gene Expression Profiling
Fluorescently labeled cDNA probes were generated by reverse transcription of mRNA prepared from control or infarcted rat hearts in the presence of Cy3 or Cy5 dCTP (Amersham). Fluorescently labeled probe pairs were applied to microarrays that contained Ϸ7000 rat heart cDNA clones and allowed to hybridize to each of the 7000 elements. Degree of hybridization at each element was quantified by sequential excitation of the 2 fluorophores with a scanning laser read at an appropriate wavelength for each emission. Differential expression values were expressed as a ratio of intensities from the two emissions where positive and negative values indicated an increase or decrease, respectively, relative to control.
An expanded Materials and Methods section is available online at http://www.circresaha.org.
Results

Preparation of Infarcted Myocardial Tissue
Heart tissue was taken from rats with healed MI to examine changes in gene expression associated with disease. Following established procedures, 2 transmural infarctions were produced by coronary artery ligation (for details, see online Materials and Methods; http://www.circresaha.org). At various time points after infarction (2, 4, 8, 12 , and 16 weeks), and from sham-operated controls, heart tissue was removed, weighed, and scored for size of the healed infarction (see Table online ; http://www.circresaha.org). Heart weight-tobody-weight measurements indicated substantial enlargements of the hearts in MI animals relative to control animals. Histological examination of the hearts revealed significant fibrosis in the region of infarction (Figure 1 ). mRNA was extracted separately from LV free wall and IVS for gene expression analysis.
cDNA Microarray Analysis of Infarcted Myocardium
Approximately 7000 cDNA clones, isolated from a normalized rat LV cDNA library, were randomly chosen for analysis on microarrays. Partial sequencing of the clones indicated that there were 4258 distinct sequences, which is a rough estimate of the number of distinct genes printed. Sequence alignment 14 of the 7000 printed clones against GenBank entries indicated that 59% matched named genes, 23% matched only expressed sequence tags (ESTs), and 18% had no significant match. Polymerase chain reaction-amplified inserts of each cDNA were printed as high-density arrays on treated glass surfaces (for details, see online Materials and Methods; http://www.circresaha.org).
The microarrayed target genes were probed with Cy3-labeled cDNA prepared from mRNA of each time point and Cy5-labeled reference cDNA prepared from sham-operated control tissue. LV and IVS samples were prepared and assayed independently. Tissues from 4 animals were pooled to improve yields in preparation of poly Aϩ RNA and to minimize variations among animals. Duplicate hybridizations were performed on the 7000-element microarray with LV and IVS tissue for all time points. All target genes that showed changes of at least 1.8-fold were reprinted onto a subarray for further analysis. The subarray was hybridized, in duplicate, with probe derived separately from LV and IVS tissue at each time point. Thus, all target genes described here were independently assayed 4 times. Expression data generated for a few target genes, in certain experiments, did not pass acceptance criteria (see online Materials and Methods; http:// www.circresaha.org). Therefore, some target genes did not produce 4 independent values, and only those genes that had at least 2 independent values were considered further. Median values were determined, and target genes that showed a decrease or increase of at least 1.8-fold at any time point were considered differentially expressed. The threshold value for differential expression of 1.8-fold proved reliable for genes that produced expression values significantly over background (data not shown). Low-level expression values, 3-to 4-fold over background, were less reproducible. Consistent determinations among genes that had multiple representation on the arrays were a testament to the method (see Figure 6 online; http://www.circresaha.org). For many genes, differential expression was observed in multiple time points, which also indicated reliability in the method.
We identified 731 cDNA clones that were differentially expressed in LV or IVS in at least 1 time point. Among these differentially expressed genes were 198 that matched only to ESTs in GenBank and 69 clones that had no significant match in GenBank. A total of 464 clones corresponded to 230 unique, named genes that were differentially expressed. Summary representations of the results are presented in this article, and a more complete report of expression data and gene identification information is available (see Figure 6 online; http://www.circresaha.org). Many of the genes identified have not been previously reported as differentially expressed in the MI model. Confirming the ability of microarrays to identify differentially expressed genes, a number of genes that showed elevated expression were previously reported as such in MI heart tissue utilizing traditional methodology. These include atrial natriuretic peptide, 4,7 sarcoplasmic/ endoplasmic reticulum Ca 2ϩ ATPase, 15 collagen, 5, 6 and fibronectin. 6 Indeed, many other investigators have found that cDNA microarray methods are reliable when compared with more traditional methods of gene expression analysis. 16 -18 
Clustering Gene Expression Patterns
We developed a computer program (GExpA) to cluster and visualize similar gene expression patterns from very large sets of data generated by microarray analysis (Q. Zheng and L.J. Garrard, unpublished program, 1999). The data collected from genes that showed differential expression were analyzed by GExpA to reveal temporal and tissuespecific patterns of gene expression. For clustering, expression values for each target gene were normalized to emphasize trends in expression changes over the magnitude of response. Within each time course, differential expression values were divided by the absolute maximum value to ensure that all values are between -1 and 1. Before normalization, insignificant median values of differential expression between -1.4 and 1.4 were set to a neutral value of 0. Expression curves were generated for each gene from the 5 time points in the LV appended to the 5 time points in IVS. An example of a cluster derived from our data is shown ( Figure 2 ). The characteristic curve of the cluster is shown together with actual curves for 10 genes that compose that cluster. As testament to the accuracy of the clustering, replicate genes within the data set were found in the same (see atrial natriuretic factor [ANF] and ribosomal protein S27 clones in Figure 2 ) or very similar clusters. Expression patterns fell into a total of 58 different clusters in this analysis. A graphic representation of the clustering of all 731 differentially expressed genes is shown in Figure 3 . Each row represents different target cDNAs, and the columns reflect the 5 time points in the LV and the 5 time points in the IVS. All genes are grouped together within their assigned expression cluster, and clusters are arranged by similarity to the other clusters. Through this visual display of the data, a number of temporal patterns are evident. In some clusters, there are consistent decreases or increases in gene expression across the time course, whereas other sets indicate transient changes in gene expression. It is also readily apparent that although certain genes are similarly altered in the LV and IVS, a majority of the patterns reveal a distinct response in these 2 regions of the heart.
Functional Clusters Within Expression Clusters
Many of the genes that displayed differential expression encode proteins with known functions, whereas others corresponded to genes of unknown function, including novel and previously identified ESTs. Genes were classified on the basis of biological function of the encoded protein using a modified version of a previously established classification scheme. 19 The classification scheme was composed of 7 major functional categories and several minor functional categories within the major categories. Genes were placed into a single class if a function of the encoded protein has been well established (for complete classification, see Figure  6 online; http://www.circresaha.org).
Within the functional groups, clustering analysis elucidated additional expression patterns. The GExpA clustering program was applied to each of the 7 major functional groups of genes that showed differential expression ( Figure 4) . The results show that there was a nonrandom distribution of expression patterns within the functional groups of genes. For example, within the Protein Expression group, nearly all of the genes showed increased expression, primarily in the LV. Although most of the elevated expression was for ribosomal proteins, genes encoding enzymes involved in protein modification and degradation were likewise enhanced. In the Cell Structure/Motility group, there are both enhanced and repressed genes. However, enhanced genes predominantly encode cytoskeletal and ECM proteins, whereas the repressed genes preferentially encode contractile proteins. Many genes in the Metabolism category encode proteins involved in energy metabolism and, within that group, lipid metabolism genes were primarily repressed. In contrast, very few genes in the categories of Cell Division (1%) and Cell/ Organism Defense (7%) were found to be differentially expressed. As no attempt was made to populate the microarray with equal representation across the various functional classes, one should not overinterpret the statistical or biological significance of the number of changes within each functional category.
Gene Expression Patterns Indicative of Cardiac Remodeling
A large number of genes that encode ECM proteins displayed enhanced expression in MI relative to a normal myocardium. Regional differences in expression profiles indicate that involvement of these proteins is more profound in the post-MI processes taking place in LV than in IVS. In addition to several types of collagen, other proteins that are structural components of the ECM were transcriptionally elevated, including fibronectin, laminin, fibrillin, fibulin, SC1/ECM2, and decorin. The expression patterns of these ECM genes in MI showed that they are elevated primarily in the LV free wall throughout the time course studied here, 2 to 16 weeks after infarction. In addition, we observed elevated expression, primarily in LV tissue, of the metalloproteinase inhibitor, TIMP-3, which appears to play a role in ECM deposition by preventing the destruction of newly produced structural components of the matrix.
It is of interest that expression profiling revealed no genes that were differentially expressed only in the IVS. There were many genes that were altered uniquely in LV, or similarly in LV and IVS, but none that were unique to IVS. Thus, although the remodeling process is different in LV and IVS, it appears that the changes in IVS are a subset of the changes in the LV. In addition, certain genes that are altered in both LV and IVS are more substantially altered in the LV, either in magnitude or duration. ANF expression, for example, was elevated in both LV and IVS, but to different extents. In LV, ANF expression continued to increase over the time course from 7-to 17-fold, whereas in IVS, ANF was consistently elevated 9-fold throughout the time course ( Figure 5) . ECM proteins such as collagen and fibronectin displayed clearly different patterns of expression between LV and IVS. In LV, these genes were elevated substantially in the early time points (2 to 4 weeks), and less so at later times. In IVS, collagen and fibronectin were elevated, but to a lesser extent than in LV ( Figure 5 ). This is consistent with a greater need for matrix deposition in the damaged region of LV. The patterns of gene expression in LV and IVS indicate that a similar programmed response to infarction is invoked in the 2 regions of heart, but there is apparent flexibility within the program to modulate the degree of response.
Also showing differential expression was SPARC (secreted protein acidic and rich in cysteine), a protein that has been implicated in control of endothelial cell interactions with ECM. 20 SPARC expression was elevated in LV tissue, but not in IVS. Recent studies have shown that SPARC transcription is elevated in regions of myocardial damage in a rat model of hypertrophy. 21 It is likely that these changes in expression of genes that encode ECM structural and regulatory proteins are important in remodeling of the surviving myocardium after an ischemic event.
An interesting result was finding elevated expression of osteoblast-specific factor-2 (OSF-2), a protein thought to be expressed uniquely in osteoblasts. 22 Expression of OSF-2 was significantly elevated in LV across the time course of the study. On clustering of the entire data set, we found that OSF-2 coclustered with several isoforms of collagen, laminin, and fibronectin ( Figure 5 ). Very little is known about the function of this protein, but it has been implicated as an extracellularly deposited protein that may establish intercellular contacts in osteoblasts. 23 Our discovery that OSF-2 is expressed in heart and that its expression clusters very closely with collagen, laminin, and fibronectin suggests that this protein may play a key role in ECM deposition, fibrosis, and tissue remodeling in MI. It remains to be determined whether OSF-2 is a structural component of ECM or is involved in regulation of matrix deposition. Of course, clustering by expression pattern alone is not sufficient to ascribe a role for OSF-2. However, combining clustered expression data and structural information for a gene will aid in predicting function.
A number of other differentially expressed genes that were identified are likely to play a role in the remodeling process. Although many of these genes have not been identified as differentially expressed in MI, they clearly Figure 4 . Clustered expression patterns of genes within functional groups. Differentially expressed genes were categorized on the basis of known functions. Clusters of expression patterns, generated within each functional group, are displayed as described in Figure  3 . Genes are labeled with a clone identification number and common name. See Figure 6 online (http://www.circresaha.org) for detailed expression data and GenBank accession numbers for each clone.
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play a role in cytoskeletal architecture. Some of the genes encode proteins that comprise structural components of the cytoskeleton, including vimentin, spectrin, and actin microfilaments. In addition, elevated expression was observed for genes that regulate cytoskeletal assembly, including thymosins B4 and B10, moesin, transgelin, and proteins of the Arp2/3 actin assembly complex p41arc, p21arc, p16arc, and Arp3. Coordinate expression patterns of these genes strongly implicates a role for the encoded proteins, particularly actin assembly, in the disease process. Although changes in cytoskeletal gene expression were likely necessary to maintain contractility, contractile proteins were not similarly affected. In fact, expression of certain genes that encode proteins related to contractile apparatus, including titin, tropomyosin 4, troponin I, and telethonin, were repressed ( Figure 4 ). Altered contractility has been described within postinfarction myocardium, 1 and these genes may play a part in that shift. Many of the differentially expressed genes encode proteins involved in energy metabolism. Notably, several lipid metabolism genes were found in expression clusters populated with genes consistently repressed across the time course in LV. Of the repressed genes, there was a prevalence for those involved in catabolism of fatty acids, including enoyl-coenzyme A (CoA) isomerase, dienoylCoA reductase, hydroyacyl-CoA dehydrogenase, longchain acyl-CoA synthase, and ketoacyl-CoA thiolase. All of these enzymes serve in the process of ␤-oxidation of fatty acids for energy production. Their coordinate repression in infarcted LV indicates a shift away from use of fatty acids as an energy source. Fatty acid catabolism is also dependent on lipoprotein lipase and CD36, a fatty acid transporter, and these genes are also repressed. It has been well established that fatty acids are primary fuels for energy production in healthy hearts. However, in response to ischemia, glucose becomes the favored energy source in recovering myocardium. 24, 25 Our data indicate that there is a long-term adaptation in expression of fatty acid metabolism genes as a means to accomplish this metabolic reprogramming.
Discussion
We have used cDNA microarrays to assess changes in gene expression that result from MI to gain insight into the underlying molecular basis of the disease. In this study, an experimental rat model was exploited to look at changes in expression as they develop over time, in particular areas of the heart, in response to an ischemic event. More than 400 different genes were found that showed altered expression in the remodeling myocardium. This survey of Ϸ4500 genes examined only a fraction of expressed genes, perhaps only 5% of all rat genes. In addition, as no effort was made in this study to select cDNAs produced from infarct tissue, certain disease-specific genes would be missed. Nonetheless, this survey revealed some clear patterns that highlight certain biological processes perturbed in MI. Both temporal and spatial patterns of altered gene expression were observed. The clustering of similar expression patterns for gene products with related function has revealed molecular footprints of biological processes that have been affected. Coordinated changes in expression of genes related to cellular and extracellular architecture are consistent with the remodeling process of the postischemic heart. A reflection of altered bioenergetics in a failing heart was evident as a systematic decrease in expression of lipid catabolism genes. It is encouraging that patterns, which are revealing of biological processes, are recognized from analysis of a limited segment of the genome, as shown here and elsewhere. 16, 26 As we rapidly approach a complete sequence of mammalian genomes, a more comprehensive assessment of gene expression will be attainable, as has been accomplished by expression profiling in yeast. 18, 27 Certain patterns were prominently revealed from expression data and are indicative of functional responses underlying MI. Expression information alone is not sufficient to establish firm functional associations among proteins. However, the type of expression data presented here is very useful in generating testable hypotheses. For instance, a large number of genes that encode cell signaling molecules displayed differential expression (Figure 4) . It is reasonable to hypothesize that some of these signaling molecules play a role in mediating remodeling processes. Similarly, it is tempting to speculate about transcription factors that showed differential expression. Coordinate changes in expression of many genes may be orchestrated by a few transcription factors of which the expression is regulated. Of particular note are the transcription factors cardiac ankyrin repeat protein (CARP), which has been implicated as a regulator of cardiac gene expression, 28 and transforming growth factor-␤-stimulated clone (TSC)-22, which acts as a transforming growth factor-␤-inducible repressor of transcription. 29 CARP and TSC-22 mRNA levels are elevated throughout the MI time course in LV and IVS (Figure 4 ), suggesting that they play a role in controlling the transcriptional response to infarction. Patterns that appear from large-scale gene expression analysis should aid in our understanding of regulatory mechanisms that mediate the physiological and pathological processes in the heart. Unique patterns of expression were revealed for 2 regions of the heart profiled in this study, LV and IVS. This is not surprising, given that disparate biological processes are taking place in these 2 regions in response to MI. In particular, there is significant tissue repair activity in the LV, which is exemplified by altered expression of ECM proteins in LV with little or no change in IVS. Indeed, it can be suggested that many of the genes that are altered only in LV play a primary role in the healing process. In comparison, genes that are altered in both IVS and LV are more likely to be associated with a more restricted response to failure, per se. Good examples of this are natriuretic peptides, ANF and brain natriuretic peptide, that are elevated in IVS and LV and are known to reduce the load on a failing heart. DNA microarrays are facilitating systematic exploration of gene expression on a genome-wide scale. Working with expanded sets of genes, more complete in number and functional characterization, should yield a wealth of information about the physiology and pathology of the heart. Comparisons of gene expression changes among different models should contribute greater understanding of the relationship between genes and disease. Much could be learned by examining cardiac gene expression changes in rats treated with pharmacological agents, such as ␤-blockers and angiotensin-converting enzyme inhibitors, that show beneficial effects. In searches for better treatments of heart failure, large-scale gene expression analyses may prove very useful in disease diagnosis and prognosis and accelerate identification of novel therapeutic targets.
